Black Rock Inc. Pacira Bio Sciences, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,006,826 shares of PCRX stock, worth $204 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,006,826
Previous 7,905,156
1.29%
Holding current value
$204 Million
Previous $231 Million
0.83%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Vanguard Group Inc Valley Forge, PA5.24MShares$133 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$57.5 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$57 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$52.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.98MShares$50.3 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.16B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...